Zepbound weight loss averages about 20.9% of total body weight at the 15 mg dose over 72 weeks, based on the SURMOUNT-1 trial. Zepbound is tirzepatide, a once-weekly injection that acts on two gut hormone pathways at once. Results build gradually across roughly 12 to 17 months, and how much you lose depends heavily on the dose you reach, your consistency, and your diet and activity. Individual results vary widely.
What Zepbound is
Zepbound is the brand name for tirzepatide, a once-weekly injection that the FDA approved for chronic weight management in adults with obesity or overweight with a weight-related condition. It is also approved to treat obstructive sleep apnea in adults with obesity. It is the same molecule as Mounjaro, which is marketed for type 2 diabetes.
What makes tirzepatide different from earlier medicines is that it is a dual agonist. It activates both the GLP-1 receptor and the GIP receptor, two hormone pathways involved in appetite, fullness, and blood sugar. GLP-1 alone has been well studied for years, but adding GIP activity appears to boost the effect on weight. If you want the mechanism in plain language, our overview of how these drugs compare in weight loss results by drug puts tirzepatide next to its peers.
In practical terms, Zepbound works mainly by reducing appetite and slowing how fast the stomach empties, so you feel full sooner and stay full longer. Many people describe a quieting of food noise, the constant background pull toward snacking. That change is what makes it easier to eat less without feeling like you are running on willpower alone. The medication does not do the work by itself, though. It creates the conditions in which sustainable diet and activity changes become realistic, and the people who pair it with those habits tend to see the strongest and most durable results.
How much Zepbound weight loss to expect
In the SURMOUNT-1 trial, adults with obesity who did not have diabetes took Zepbound for 72 weeks alongside diet and activity guidance. At the highest 15 mg dose, participants lost about 20.9% of their starting body weight on average. Many people at the top dose lost 25% or more. For someone starting at 250 pounds, a 20.9% average works out to roughly 52 pounds.
That is higher than what semaglutide produced in its own pivotal trial. In STEP-1, Wegovy (semaglutide) averaged about 15% weight loss over 68 weeks. A direct head-to-head comparison came later: in the SURMOUNT-5 trial, tirzepatide outperformed semaglutide, with roughly 20% loss versus about 14%. That does not mean Zepbound is right for everyone, but on average it tends to produce more loss. Our side-by-side breakdown of Wegovy versus Zepbound walks through the trade-offs.
It helps to put these percentages in real numbers. A 15% loss on a 220-pound starting weight is about 33 pounds, while a 20.9% loss is closer to 46 pounds. For many people, differences in that range translate into meaningful changes in blood pressure, blood sugar, joint comfort, and sleep. That said, the headline averages come from carefully run clinical trials in which participants were supported and monitored closely. Real-world results are often a bit lower, mostly because staying on a medication and reaching the top dose is harder outside a study. That is not a reason for discouragement, only a reason to anchor your expectations to your own dose, tolerance, and habits rather than to the best-case trial number.
Dose matters: the higher you go, the more you tend to lose
Zepbound weight loss is dose-dependent. Treatment starts low to let your body adjust, then steps up over time. The starting dose is 2.5 mg weekly, which is not considered a treatment dose, and it titrates up toward a maximum of 15 mg. Maintenance doses are 5, 10, or 15 mg. In general, higher maintenance doses produce more weight loss, though the right dose for you is the lowest one that gives a good result with tolerable side effects.
| Maintenance dose | Approximate average total weight loss |
|---|---|
| 5 mg weekly | Around 15% of body weight |
| 10 mg weekly | Around 19% of body weight |
| 15 mg weekly | Around 20.9% of body weight |
These figures are trial averages over 72 weeks and are meant to show the trend, not to predict your personal outcome. Your clinician decides how quickly to titrate and where to hold your dose. For the full schedule and how the steps work, see our guide to Zepbound dosage.
The Zepbound weight loss timeline
Weight loss on Zepbound is gradual, not sudden. It follows a predictable shape that mirrors most GLP-1 based treatment, which we cover in detail in the GLP-1 weight loss timeline. Here is what the arc usually looks like.
| Timeframe | What tends to happen |
|---|---|
| Weeks 1 to 20 | Titration phase. Doses step up every few weeks. Early loss is usually modest as your body adjusts. |
| Weeks 20 to 52 | Loss accelerates once you reach a maintenance dose. This is often the steepest stretch. |
| Around week 72 | Loss flattens toward a plateau, roughly 12 to 17 months in. Many people are near their peak result here. |
If the scale barely moves in the first month or two, that is expected. The larger changes come after you have titrated up. Setting expectations early helps, which is why we put together a piece on realistic weight loss goals on GLP-1 medications.
Why individual results vary so much
The averages above hide a wide range. Some people lose far more than 20%, and some lose much less. Several factors drive the difference:
- Dose reached. People who tolerate and stay on 15 mg tend to lose more than those who stop at 5 mg.
- Adherence. Weekly consistency matters. Missed or delayed doses blunt results.
- Diet and activity. Zepbound reduces appetite, but the food choices and movement you pair it with shape the outcome.
- Biology. Genetics, baseline weight, and other health conditions all play a role that is hard to predict in advance.
Side effects, most often nausea and other digestive symptoms, can also affect how high a dose you can comfortably reach. Our overview of Zepbound side effects explains what is common and what is not, and the deeper Zepbound clinical trial results show how the numbers were measured.
Protecting muscle and holding onto results
When you lose weight quickly, some of what you lose is muscle, not just fat. Two habits help preserve lean mass during Zepbound weight loss: eating adequate protein and doing regular resistance training. This matters for strength, metabolism, and long-term maintenance.
It is also important to understand what happens if you stop. Weight is often partly regained after coming off the medication, because the appetite signals it was managing return. Many clinicians view obesity as a chronic condition and treat Zepbound as a long-term therapy rather than a short course. Any decision to start, adjust, or stop should be made with your clinician, who can weigh your full health picture.
Scientific References
4 sources- 1
Jastreboff AM, Aronne LJ, Ahmad NN, et al.
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
New England Journal of Medicine · 387(3) · 2022PMID: 35658024
NEJM - 2
Wilding JPH, Batterham RL, Calanna S, et al.
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1)
New England Journal of Medicine · 384(11) · 2021PMID: 33567185
NEJM - 3
Drucker DJ
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Cell Metabolism · 27(4) · 2018PMID: 29617641
PubMed - 4
U.S. Food and Drug Administration
Prescribing information: Zepbound (tirzepatide)
U.S. Food and Drug Administration · 2024
References open in a new tab. Content is reviewed against peer-reviewed literature as part of our editorial policy.
About the author
Modern Weight Science Editorial Team
Editorial Team
Evidence-based research and educational content focused on metabolism, appetite regulation, and sustainable weight management. Our team synthesizes peer-reviewed research into clear, accessible guidance for informed health decisions.
Every claim is checked against peer-reviewed research through our review process and fact-checking policy.
Frequently Asked Questions
How much weight can you lose on Zepbound?
In the SURMOUNT-1 trial, adults averaged about 20.9% of their total body weight lost at the 15 mg dose over 72 weeks. Many people at the top dose lost 25% or more. Results at lower maintenance doses are smaller, and individual outcomes vary widely.
How long does it take Zepbound to work?
Zepbound weight loss is gradual. The first roughly 20 weeks are a titration phase with modest early loss, then loss accelerates and flattens toward a plateau around 72 weeks, which is roughly 12 to 17 months.
Is Zepbound better than Wegovy for weight loss?
On average, tirzepatide has produced more weight loss than semaglutide. In the head-to-head SURMOUNT-5 trial, tirzepatide beat semaglutide at roughly 20% versus 14%. Even so, the best choice depends on your health, tolerance, and clinician's guidance.
Does a higher Zepbound dose mean more weight loss?
Generally yes. Zepbound weight loss is dose-dependent, and the highest 15 mg dose produced the largest average loss in trials. The right dose for you is the lowest one that gives a good result with tolerable side effects, decided with your clinician.
Will I regain weight if I stop Zepbound?
Weight is often partly regained after stopping, because the appetite signals the medication was managing return. Many clinicians treat obesity as a chronic condition and view Zepbound as a long-term therapy. Talk to your clinician before changing or stopping treatment.
How can I keep muscle while losing weight on Zepbound?
Eating adequate protein and doing regular resistance training help preserve lean muscle during rapid weight loss. This supports strength, metabolism, and long-term maintenance. This article is informational, so work with a clinician on a plan that fits you.
Continue learning
Where to read next
Not medical advice. This guide is for general education only. GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.